DFG supports a new Clinical Research Unit (CRU 329) focusing on disease pathways in podocyte injury

19.12.2017 | More than 200 million people worldwide suffer from chronic kidney diseases (CKD). Glomerular disorders account for the majority of cases of CKD.


Discovery of choline transporter mutations in a novel form of congenital myasthenic syndrom facilitates treatment

04.11.2017 | of patients reported by the teams of Sebahattin Cirak (Dept. of Pediatrics, Univ. Hospital of Cologne and the CMMC), Andrew Crosby and Emma Baple...


EMBO elects Alvaro Rada Iglesias as EMBO Young Investigator 2017

25.10.2017 | to further promote his research to uncover the transcriptional regulatory principles of mammalian embryogenesis and human congenital disease.


Uncovering the cellular mechanisms of morpholino antisense drug delivery to muscles.

17.10.2017 | A direct implications for multi-exon skipping strategies for Duchenne muscular dystrophy (DMD). A breakthrough has been achieved in the understanding...


New approaches in targeted cancer therapy - systematic kinase inhibitor profiling

26.09.2017 | Scientists in the research groups of Roman Thomas and Martin Sos at Cologne University Hospital and University of Cologne have tested the effects of...


DFG supports the Klenk Symposium in Molecular Medicine on “Tissue regeneration, wound healing and fibrosis:

23.07.2017 | Translating basic concepts into regenerative therapy” taking place from Oct. 15 - 17, 2017 organized by the CMMC at the Medical Campus, University of...


Upcoming seminars